Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
01 6Northera
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 415
2019 Revenue in Millions : 379
Growth (%) : 10
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 101
2020 Revenue in Millions : 408
Growth (%) : -74
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurogenic Orthostatic Hypotension
Currency : USD
2015 Revenue in Millions : 4
2014 Revenue in Millions : 71
Growth (%) : 1675%
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 279
2016 Revenue in Millions : 185
Growth (%) : 51
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 271
2017 Revenue in Millions : 247
Growth (%) : 10%
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 349
2018 Revenue in Millions : 271
Growth (%) : 29
